Daiichi Sankyo Company, Limited (DSKYF)

USD 26.5

(0.0%)

Long Term Debt Summary of Daiichi Sankyo Company, Limited

  • Daiichi Sankyo Company, Limited's latest annual long term debt in 2024 was 101.31 Billion JPY , down -0.37% from previous year.
  • Daiichi Sankyo Company, Limited's latest quarterly long term debt in 2024 FY was 101.31 Billion JPY , down -0.37% from previous quarter.
  • Daiichi Sankyo Company, Limited reported annual long term debt of 101.69 Billion JPY in 2023, down -28.92% from previous year.
  • Daiichi Sankyo Company, Limited reported annual long term debt of 143.06 Billion JPY in 2022, down -12.47% from previous year.
  • Daiichi Sankyo Company, Limited reported quarterly long term debt of 101.31 Billion JPY for 2024 FY, down -0.37% from previous quarter.
  • Daiichi Sankyo Company, Limited reported quarterly long term debt of 101.5 Billion JPY for 2024 Q2, down -0.09% from previous quarter.

Annual Long Term Debt Chart of Daiichi Sankyo Company, Limited (2024 - 2000)

Historical Annual Long Term Debt of Daiichi Sankyo Company, Limited (2024 - 2000)

Year Long Term Debt Long Term Debt Growth
2024 101.31 Billion JPY -0.37%
2023 101.69 Billion JPY -28.92%
2022 143.06 Billion JPY -12.47%
2021 163.44 Billion JPY -11.08%
2020 183.81 Billion JPY -16.67%
2019 220.58 Billion JPY -15.34%
2018 260.56 Billion JPY -7.12%
2017 280.54 Billion JPY 55.0%
2016 181 Billion JPY -9.95%
2015 201 Billion JPY -23.66%
2014 263.28 Billion JPY 31.16%
2013 200.74 Billion JPY 3.51%
2012 193.92 Billion JPY -13.44%
2011 224.03 Billion JPY -17.31%
2010 270.92 Billion JPY 330.49%
2009 62.93 Billion JPY 349533.33%
2008 18 Million JPY -98.83%
2007 1.53 Billion JPY -54.58%
2006 3.37 Billion JPY 0.06%
2005 3.37 Billion JPY -27.79%
2004 4.67 Billion JPY -26.86%
2003 6.38 Billion JPY 0.0%
2002 - JPY 0.0%
2001 - JPY 0.0%
2000 - JPY 0.0%

Peer Long Term Debt Comparison of Daiichi Sankyo Company, Limited

Name Long Term Debt Long Term Debt Difference
AstraZeneca PLC 22.33 Billion USD -353.643%
Bristol-Myers Squibb Company PFD CONV 2 38.18 Billion USD -165.338%
CSPC Pharmaceutical Group Limited 107.05 Million USD -94534.684%
Clarus Therapeutics Holdings, Inc. - USD -Infinity%
Novartis AG 20.03 Billion USD -405.71%
PT Kalbe Farma Tbk. 19.39 Million USD -522355.36%